This account is no longer actively managed. Please follow all our activity on the following channels or visit our website: clearnotehealth.com/ linkedin.com/company/clearno… bsky.app/profile/clearnotehe… Thank you!

ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for @theNCI’s Vanguard Study. Read the PR: clearnotehealth.com/press-re…

Did you know that Type 2 Diabetes can increase the risk of pancreatic as well as other cancers? Recently, Dr. Steve Edelman and the Taking Control Of Your Diabetes (@TCOYD) team highlighted the connection between #diabetes and #pancreaticcancer: tcoyd.org/2024/09/the-connec…

Avantect Ovarian Cancer Test Receives CPT Code and Preliminary Payment Determination from the Centers for Medicare and Medicaid Services Learn more: clearnotehealth.com/press-re…

📢 ClearNote Health will be at the 14th World CB & CDx Boston Summit, Sept 3rd-6th. 📍Find us at #Booth35 and learn more about the advantages of the Virtuoso Epigenomics Platform for longitudinal analysis in your translational research. #drugdevelopment #therapyresponse